Clinical performance of human papillomavirus based cervical cancer screening algorithm: The result of a large Danish implementation study

被引:0
|
作者
Lindquist, Sofie [1 ]
Kjaer, Susanne K. [1 ,2 ,3 ]
Frederiksen, Kirsten [4 ]
Ornskov, Dorthe [5 ]
Petersen, Lone Kjeld [6 ,7 ]
Munk, Christian [1 ]
Waldstrom, Marianne [8 ,9 ]
机构
[1] Danish Canc Inst, Unit Virus Lifestyle & Genes, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Dept Gynecol, Rigshosp, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[4] Danish Canc Inst, Unit Stat Biostat & Registry, Copenhagen, Denmark
[5] Odense Univ Hosp, Dept Pathol, Odense, Denmark
[6] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark
[7] Univ Southern Denmark, Dept Clin Med, Odense, Denmark
[8] Aarhus Univ Hosp, Dept Pathol, Aarhus, Denmark
[9] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
关键词
cervical cancer; cervical intraepithelial neoplasia; HPV testing; human papillomavirus; screening; BIOPSIES;
D O I
10.1111/aogs.14915
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
IntroductionIn Denmark, where human papillomavirus (HPV) -based cervical cancer screening is being implemented, the aim of this pilot implementation study was to test a specific screening algorithm, assess follow-up examination attendance, and measure the proportion of precancer lesions found in relation to the number of women referred for colposcopy.Material and MethodsFrom May 2017 to December 2020, 36 417 women in the uptake area of the Department of Pathology, Vejle Hospital, Region of Southern Denmark, were included in the HPV group. Women positive for HPV16/18 irrespective of cytology and women positive for other high-risk HPV (hrHPV) types having concomitant abnormal cytology were referred directly to colposcopy. Women positive for other hrHPV types and normal cytology were referred to repeat screening after 12 months, and hrHPV negative to routine screening after three years. We obtained information on screening results and subsequent histological diagnosis from the Danish Pathology Databank through September 2022.Results3.6% of the women were referred to colposcopy after primary screening, 5% to repeat screening after 12 months, and 91.4% back to routine screening. High follow-up rates were observed: 96% attended colposcopy after primary screening, with 91% attending colposcopy after repeat screening. CIN3+ was detected at colposcopy following the primary screening in 28.1% of HPV16/18-positive women and 18.2% of those positive for other hrHPV types with concomitant abnormal cytology. Of the women with other hrHPV and simultaneous ASCUS/LSIL, 8% had CIN3+. At the repeat screening, 43% had become hrHPV negative, 55% were persistently positive for other hrHPV, and 2% had turned positive for HPV16/18. At the colposcopy following repeat screening, 10.1% of the women positive for other hrHPV were diagnosed with CIN3+, in comparison with 11.1% of the HPV16/18-positive women.ConclusionsIn this pilot implementation study, an algorithm for HPV-based screening was evaluated in a Danish setting. The results demonstrated high attendance at follow-up examinations and provided insights into the number of colposcopy referrals and the detection of CIN2 and CIN3+ cases. The results suggest that women testing positive for other hrHPV in combination with ASCUS/LSIL at primary screening could potentially be referred to repeat screening instead of an immediate colposcopy. This Danish pilot study assessed an HPV-based screening algorithm, revealing a high follow-up attendance. Positive hrHPV with ASCUS/LSIL may motivate repeat screening after 12 months, potentially reducing immediate colposcopy referrals while maintaining effective detection of CIN2 and CIN3+ cases.image
引用
收藏
页码:1781 / 1788
页数:8
相关论文
共 50 条
  • [21] Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand
    Sharma, M.
    Ortendahl, J.
    van der Ham, E.
    Sy, S.
    Kim, J. J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (02) : 166 - 176
  • [22] Population-based cohort study assessing the efficacy of cervical cytology (Pap smear) and human papillomavirus (HPV) testing as modalities for cervical cancer screening
    Morisada, Tohru
    Saika, Kumiko
    Saito, Eiko
    Kono, Kanako
    Saito, Hiroshi
    Aoki, Daisuke
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (05) : 495 - 498
  • [23] Cervical cancer prevention: Human papillomavirus testing as primary screening
    Desai, Shreya
    Zhu, Michelle J.
    Lapidos-Salaiz, Ilana
    CANCER, 2022, 128 (05) : 939 - 943
  • [24] The value of human papillomavirus detection in primary cervical cancer screening
    Baay, MFD
    Weyler, J
    Vermorken, JB
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2004, 25 (06) : 665 - 669
  • [25] Effect of introducing human papillomavirus genotyping into real-world screening on cervical cancer screening in China: a retrospective population-based cohort study
    Dong, Binhua
    Zou, Huachun
    Mao, Xiaodan
    Su, Yingying
    Gao, Hangjing
    Xie, Fang
    Lv, Yuchun
    Chen, Yaojia
    Kang, Yafang
    Xue, Huifeng
    Pan, Diling
    Sun, Pengming
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [26] Human papillomavirus genotype in cervical cancer: A population-based study
    Lai, Chyong-Huey
    Huang, Huei-Jean
    Hsueh, Swei
    Chao, Angel
    Lin, Cheng-Tao
    Huang, Shang-Lang
    Chao, Fang-Yu
    Qiu, Jian-Tai
    Hong, Ji-Hong
    Chou, Hung-Hsueh
    Chang, Ting-Chang
    Chang, Chee-Jen
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (09) : 1999 - 2006
  • [27] Cervical cancer prevention and screening: the role of human papillomavirus testing
    Aref-Adib, Mehrnoosh
    Freeman-Wang, Theresa
    OBSTETRICIAN & GYNAECOLOGIST, 2016, 18 (04) : 251 - 263
  • [28] Human Papillomavirus Messenger RNA Assay for Cervical Cancer Screening The Shenzhen Cervical Cancer Screening Trial I
    Wu, Ruifang
    Belinson, Suzanne Elizabeth
    Du, Hui
    Na, Wulan
    Qu, Xinfeng
    Wu, Ruosong
    Liu, Ying
    Wang, Chun
    Zhou, Yanqiu
    Zhang, Lijie
    Belinson, Jerome L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (08) : 1411 - 1414
  • [29] HUMAN PAPILLOMAVIRUS IN FALSE-NEGATIVE ARCHIVAL CERVICAL SMEARS - IMPLICATIONS FOR SCREENING FOR CERVICAL-CANCER
    WALBOOMERS, JMM
    HUSMAN, AMD
    SNIJDERS, PJF
    STEL, HV
    RISSE, EKJ
    HELMERHORST, TJM
    VOORHORST, FJ
    MEIJER, CJLM
    JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (08) : 728 - 732
  • [30] Clinical Performance of a Dedicated Urine-Based Assay for the Detection of Human Papillomavirus and Cervical Intraepithelial Neoplasia
    Zhao, Yun
    Zhao, Lijun
    Wang, Zhaohuang
    Cui, Shuhui
    Ren, Chenchen
    Yang, Li
    Bai, Yang
    Zhu, Yuanhang
    Xie, Jingyan
    Li, Yujuan
    Wu, Xiaoqing
    Feng, Jing
    Man, Shanqing
    Huang, Longmei
    Li, Xiaoqi
    Yu, Xiaotian
    Wang, Jianliu
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2023, 15 : 1909 - 1916